Delayed onset anterior uveitis and macular edema after cessation of pembrolizumab

PURPOSE: To report a case of macular edema and anterior uveitis that developed 5 months after discontinuation of pembrolizumab, an immune checkpoint inhibitor. OBSERVATIONS: A 67-year-old man with a history of metastatic clear cell renal cell carcinoma was referred for evaluation of bilateral macula...

Descripción completa

Detalles Bibliográficos
Autores principales: Men, Mauranda, Tsui, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237938/
https://www.ncbi.nlm.nih.gov/pubmed/35774195
http://dx.doi.org/10.1016/j.ajoc.2022.101631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237938/
https://www.ncbi.nlm.nih.gov/pubmed/35774195
http://dx.doi.org/10.1016/j.ajoc.2022.101631

Ejemplares similares